Abstract
The development of sensitive and versatile mass spectrometric methodology has fuelled interest in the analysis of metabolites and drugs in unconventional biological specimens. Here, we discuss the analysis of eight human matrices—hair, nail, breath, saliva, tears, meibum, nasal mucus and skin excretions (including sweat)—by mass spectrometry (MS). The use of such specimens brings a number of advantages, the most important being non-invasive sampling, the limited risk of adulteration and the ability to obtain information that complements blood and urine tests. The most often studied matrices are hair, breath and saliva. This review primarily focuses on endogenous (e.g. potential biomarkers, hormones) and exogenous (e.g. drugs, environmental contaminants) small molecules. The majority of analytical methods used chromatographic separation prior to MS; however, such a hyphenated methodology greatly limits analytical throughput. On the other hand, the mass spectrometric methods that exclude chromatographic separation are fast but suffer from matrix interferences. To enable development of quantitative assays for unconventional matrices, it is desirable to standardize the protocols for the analysis of each specimen and create appropriate certified reference materials. Overcoming these challenges will make analysis of unconventional human biological matrices more common in a clinical setting.
This article is part of the themed issue ‘Quantitative mass spectrometry’.
Keywords: clinical analysis, toxicology, hyphenated techniques, mass spectrometry, non-invasive sampling
1. Introduction
Unconventional biological matrices have recently attracted much attention. They are perceived as carriers of chemical information on the human organism. Such matrices (collected in a non-invasive manner) include hair, nail, breath, saliva, tears, meibum, nasal mucus and skin excretions. The greatest interest comes from the fields of clinical chemistry [1,2], toxicology [3] and forensics [4]. This interest can be—in part—attributed to the success of mass spectrometry (MS). In fact, MS is a versatile technique of chemical analysis—often used in molecular characterization of biological matrices [5]. Development of very sensitive analytical methods, based on MS, enables detection of various substances at very low concentrations [6]. Thus, it is often possible to detect trace quantities of a drug after the administration of a single dose. Most clinical studies are based on the analyses of standard matrices such as blood, urine, faeces or tissue biopsy material. However, quantitative analysis of molecules present in the unconventional matrices can provide relevant complementary information. Thus, in recent years, the analysis of unconventional specimens gained importance.
In the areas of clinical analysis, toxicology and forensics, both the identities and the quantities of chemical substances matter. For example, certain trace essential metals (e.g. manganese) should be present at low concentrations in the human body. However, when their concentrations exceed certain thresholds, they become harmful or even poisonous [7]. Then again, low-molecular-weight compounds—present in certain types of cells, tissues or organs—help to maintain physiological homeostasis. However, their elevated concentrations may indicate a state of disease [8]. Thus, measurements of relative or absolute quantities of substances in human biological specimens can help to understand the inner workings of biological systems, and to identify abnormal physiological states. The assays involving unconventional specimens target various drugs of abuse (cocaine, opiates, amphetamines and cannabinoids) [1,4,9,10], pharmaceuticals [2], metabolites of ethyl alcohol (fatty acid ethyl esters and ethyl glucuronide) [11], doping agents [12], environmental contaminants (e.g. pesticides, heavy metals, organochlorides) [13,14] as well as essential and toxic elements [15].
The decision whether to choose conventional or unconventional biological specimens for analysis is influenced by several factors. If a patient (or a doctor) had a choice which biological matrix to choose for examination, they would consider invasiveness, stability, possible contamination or adulteration, extent of sample preparation and the ability to provide retrospective results (figure 1). Undoubtedly, a big advantage of testing unconventional specimens is that they can easily be collected in a non-invasive manner. The non-invasive specimen collection is especially important during routine tests, when multiple specimens need to be obtained from the same person or when under-age patients need to be examined. Another important advantage is that the risk of adulteration or substitution of the unconventional specimen is very low because its collection can be directly observed (which is unlikely in the case of urine collection). This feature is very important, especially in the case of anti-doping screening conducted during sporting events. In the case of hair and nail specimens, benefits include a large temporal window of chemical monitoring and the possibility to perform retrospective analysis [16]. Even after a single dose of a drug, a small amount of an analyte can be detected long (even several months) after the drug administration [17]. Retrospective analysis is especially useful in cases of suspected drug abuse or intoxication with sedatives in drug-facilitated crimes [18]. On the other hand, analysis of hair or nails of mothers and newborns can bring insights into fetal stress related to a mother's stressful life [19], administration of drugs [20] or consumption of alcohol [21] during pregnancy.
Figure 1.
Factors influencing the decision whether to choose conventional or unconventional biological specimens for clinical analysis, toxicology and forensics. (Online version in colour.)
Analysis of every biological matrix has its own advantages and shortcomings. The biggest challenge in chemical analysis of unconventional specimens is that the analytes are often present at very low concentrations (down to the picogram per millilitre level) [22]. Moreover, in some cases, only small amounts of the biological material can be collected. For example, the typical total volume of tears present in one eye ranges from approximately 5 to 10 µl [23]. In the case of hairs and nails, owing to the complexity of the keratinized matrix, specimens require extensive and time-consuming preparation. Although non-invasive hair or nail collection is a great advantage, such matrices are exposed to contamination from the environment, food or cosmetics. Another major problem is the lack of proper standardization of protocols for analysis of unconventional matrices and the lack of certified reference materials (CRMs)—required for conducting high-quality analyses (nowadays, only CRMs for hair are available [24,25]). However, the Society of Hair Testing has published several guidance documents describing the examination of drugs and doping agents in hair [26]. Thus, hair analysis has already found multiple applications in clinical and forensic toxicology as a complementary methodology to standard blood and urine analyses. More information about distinct advantages and challenges in the analysis of unconventional matrices, discussed in this review, is provided in table 1.
Table 1.
Application of MS in chemical analysis of unconventional human biological specimens. VOCs, volatile organic compounds.
no. of papersa |
||||||
---|---|---|---|---|---|---|
specimen | T | T/A | advantages | challenges | major objectives | analytes of interest |
hair | 24 | 294 |
|
|
|
|
breath | 16 | 160 |
|
|
|
|
saliva | 14 | 182 |
|
|
|
|
sweat | 4 | 46 |
|
|
|
|
tears | 2 | 27 |
|
|
|
|
nail | 0 | 19 |
|
|
|
|
mucus | 0 | 8 |
|
|
|
|
aNumber of papers listed in the PubMed database. Searched phrases: ‘name of the specimen’ and ‘mass’ and ‘spectrometry’ and (‘quantitative’ or ‘quantification’ or ‘quantity’ or ‘quantify’ or ‘quantified’ or ‘quantitate’ or ‘quantitated’ or ‘quantifying’) and (‘human’ or ‘humans’) in the title of the paper (T) or title/abstract (T/A). The results of the search also include analyses of metallic species and large molecules. In the case of ‘mucus’, only the number of papers related to nasal mucus is given. The database was accessed on 30 May 2016.
The past two decades have brought various developments related to mass spectrometric analysis of unconventional biological matrices. The analyses presented below were mostly based on the hyphenation of liquid or gas chromatography (LC, GC) with MS [4,12]. The disclosed methods provide good analytical sensitivity and quantitative capabilities and enable analysis of multiple substances in single chromatographic runs. Quantification by MS can be achieved because (within a certain concentration range) the intensity of the signal related to an analyte is proportional to the amount of that analyte. Nevertheless, to obtain quantitative results, additional analyses with known amounts of the standard compounds must be performed (calibration, standard addition). Beside LC- and GC-MS, other MS-related techniques and pre-treatment stages have also been used, for example: inductively coupled plasma (ICP), laser desorption/ionization (LDI), desorption electrospray ionization (DESI), proton transfer reaction (PTR), selected-ion flow-tube, ion mobility and isotope ratio. For instance, ICP-MS enabled simultaneous multi-element analyses with very low detection limits, even down to the ppt level. In one study, an ICP-MS analysis of two hairs obtained from Napoleon Bonaparte revealed very high concentrations of arsenic (42.1 and 37.4 ng mg−1), which were approximately 40 times higher than the normal values [27]. This result supported the hypothesis of Napoleon's possible intoxication with arsenic, although it did not clarify the cause of his death. Matrix-assisted laser desorption/ionization (MALDI-MS) has been employed, for example, to image incorporation of a drug into the hair matrix [28], and to identify fungal species in infected nails [29]. However, quantitative capabilities of this technique are generally considered to be limited (for examples of quantitative applications of LDI-MS techniques, see other articles in this theme issue). In one impressive demonstration, DESI-MS was applied for in vivo analysis of metabolites and drugs sampled directly from the surface of fingertip [30]. PTR-MS was used to monitor the breath of a patient undergoing surgery [31]. On the other hand, isotope-ratio MS was used to determine the isotopic composition of 13C, 15N, 2H and 18O in stable matrices such as hair and nail [32].
In this review, we summarize the major trends in quantitative chemical analysis of unconventional human biological matrices by means of MS. First, we discuss specific aspects of quantitative MS applied to unconventional biological matrices. Second, we provide a brief description of each of these matrices, emphasizing distinct advantages and disadvantages of using every type of matrix. We also discuss the main directions in the research on MS analysis of those matrices (see also table 1). Owing to space constraints, examples of procedures and applications of MS methods are described in more detail in the electronic supplementary material. Finally, we draw conclusions from the past experience in the area, and outline future trends in quantitative analysis of unconventional human biological matrices. Note that the procedures involving human subjects described below should be performed by qualified and licensed medical professionals in agreement with the relevant regulations.
2. Important aspects of quantitative mass spectrometry of unconventional biological matrices
(a). Sample versus specimen
Before moving on to further discussion, it is necessary to note that the terms ‘specimen’ and ‘sample’ refer to two different concepts [33]. ‘Specimen’ is defined as ‘a specifically selected portion of a material taken from a dynamic system’, while ‘sample’ is defined as ‘a portion of material selected from a larger quantity of material’ [34]. Owing to the intrinsic inhomogeneity of dynamic biological systems (tissues, biofluids), it is virtually impossible to collect two biological specimens with exactly the same chemical composition. To perform reliable analysis, it is important to ensure collection of ‘representative specimens’, which reflect momentary compositions of the target tissues or biofluids, relevant to the physiological state of the subject.
(b). Specimen collection
One of the advantages of mass spectrometric analysis is that only a small amount of secondary sample (pretreated specimen) is required (e.g. approx. 100 µl in typical LC-MS analysis). However, in the case of some unconventional human biological matrices, even collection of comparable volumes may be cumbersome. The ‘low-volume problem’ is particularly related to collection of sweat, tears, saliva and nasal mucus. Although there exist methods to stimulate tissues for excretion of larger volumes of sweat, tears and saliva, it must be ensured that such methods do not significantly affect the analysis result. For example, a simple method to induce sweating is to do physical exercise. However, physical activity may affect the composition of the skin excretions. One standardized method uses pharmacological stimulation of sweating. It involves application of an alkaloid (pilocarpine) to the skin [35]. In this approach, pilocarpine is first administered to the skin by means of iontophoresis carried out over 30 min. Subsequently, within the next 30 min, approximately 50–60 µl of sweat fluid is collected. A commercial system called Macroduct is used to collect such volumes of sweat. The assay facilitates diagnosis of cystic fibrosis in infants [36]. Nonetheless, this approach is considered to be invasive to the human body because an electric potential (a few tens of volts at a current of approx. 1.5 mA) is applied to the skin to facilitate iontophoresis of the alkaloid drug. Moreover, the collected sweat specimens become contaminated with large amounts of pilocarpine. Alternatively, special collectors—in the form of an absorbing wipe, pad, patch, sponge or strip—can be used to obtain small amounts of sweat, tears, saliva and nasal mucus. In these cases, high recovery of analytes from the sampling material has to be ensured. Moreover, the absolute concentration of analytes may be difficult to determine, because the volume of the collected specimen is hard to estimate.
(c). Specimen preparation and matrix effects
When a sufficient amount of a representative specimen has already been collected, one can perform direct mass spectrometric analysis without extensive sample preparation [37]. In the cases of nail and hair, extensive sample preparation is normally inevitable. Most importantly, the target analytes need to be extracted from a rigid keratinized matrix. Some analytical platforms are more compatible with such solid specimens. In the case of analysis by MALDI-MS, hair and nail specimens only need to be rinsed, and an organic matrix needs to be deposited to promote absorption of photonic energy and ionization. Small volumes of liquid-phase specimens of sweat, tears or saliva can be directly injected to the LC or GC columns. In many cases, only dilution and centrifugation are necessary. Removal of solid particles is critical to prevent clogging of the flow lines. Single-step protein precipitation can be performed with an organic solvent [38,39]. Certainly, such simplified sample treatment can still shorten the lifetimes of chromatographic columns.
In general, a lack of extensive sample preparation reduces the overall time of analysis and minimizes the biases related to multi-step sample-handling procedures. Nonetheless, MS is vulnerable to matrix interferences [40]. Matrix components often suppress or enhance ionization of the analytes. High amounts of non-volatile salts (e.g. NaCl or KCl) in the specimens such as sweat, tears or mucus cause significant ion suppression. In addition to the negative effect of ion suppression on analysis, the variable chemical composition of biological specimens can considerably affect the quality of the MS results, and lower their usefulness while drawing clinically relevant conclusions. The common solutions to the matrix-interference problem in MS include: (i) specimen/sample dilution, (ii) removing matrix salts or macromolecules prior to analysis (e.g. by extraction), and (iii) application of chromatographic separation. It is also possible to compensate for possible matrix effects related to variability and instability of the ionization process by using isotopically labelled chemical standards. Such standards are added to the prepared specimen. The signal of the isotopically labelled standard is then used to normalize the signal of the analyte. Isotopically labelled standards are chemically identical to the analytes. Thus, they generally give better results than chemical standards that are structurally different from the analytes. Unfortunately, the cost of isotopically labelled chemicals is high while their availability is limited. One imaginable solution for an analytical laboratory is to hire an organic chemist who could synthesize such isotopically labelled standards for specific analyses.
(d). Recovery
Another challenge in the analysis of unconventional specimens is the efficient extraction of the analytes of interest from the matrix or from the material used for specimen collection (e.g. absorbing wipe, pad, patch or strip). However, the efficiency of extraction may be limited due to the physical and chemical properties of the analyte and the internal structure of the specimen matrix. Certain amounts of the analytes can be lost through adsorption on surfaces, and degraded during extensive sample/specimen manipulation and prolonged storage. Only high recovery of the analyte ensures accurate and precise quantification. Thus, there is a need to develop efficient methods of extraction and concentration of trace molecules of interest present in unconventional matrices. Isotopically labelled standards are very useful to evaluate the recoveries of the sample treatment steps.
(e). Verification of the results
Validation of the analytical methodology is normally required to ensure high reliability of the quantitative analysis. Bioanalytical method validation normally includes the assessment of: selectivity, limit of quantification, limit of detection, sensitivity, calibration range, accuracy, precision (repeatability and reproducibility), matrix effects and stability of the analyte in the biological matrix [41,42]. During the validation process, a high-quality standard of the analyte of interest is spiked into a biological matrix. A matrix comparable to the matrix of the studied specimens should be used except that it should not contain the analyte species. In the case of unconventional matrices, it might be problematic to find a blank matrix (especially to study endogenous substances). Owing to the limited availability of blank matrices, isotopically labelled standards are recommended for validation of MS methods. They can be added to the specimen matrix that contains certain amounts of the target analytes. In some cases, alternative solutions to the above problem exist. For example, artificial tear solution, which is easily accessible in many pharmacies (as an over-the-counter medication), can be used as a blank matrix during method development for tear analysis [43]. However, artificial tear solution contains mostly water and salts (e.g. NaCl and KCl), while real tear fluid contains various organic molecules. In one study, an artificial sweat solution containing ammonium chloride, lactic acid, urea, acetic acid and sodium chloride dissolved in deionized water (pH adjusted to 4.7) was prepared [44]. In another report, pigs' hoofs were used as a substitute for human nail matrix [45]. In addition, in the final step of the validation process, CRMs are normally required. However, as we mentioned above, nowadays, only CRMs for hair are available. Alternatively, reference materials can be prepared in-house. For example, matrix-matched standards in a tablet form were prepared to enable quantitative analysis by means of direct solid sampling with laser ablation ICP-MS [46].
An important point in the evaluation of MS results for quantitative analysis is to verify the presence of adduct ions and the occurrence of fragmentation during and after ionization (in-source decay and post-source decay). In fact, in some cases, quantitative analyses are based on such adduct or fragment ion signals (single/multiple reaction monitoring mode). In these cases, one needs to select the adduct/fragment signals that represent high sensitivity (i.e. correlate with concentrations of the original analytes) and high repeatability.
3. Unconventional matrices in clinical analysis, toxicology and forensics
Because most of the unconventional matrices, highlighted here, are quite different in terms of their main chemical composition and physical properties, the early stages of analysis procedures have to be customized to specific matrices. However, the secondary samples derived from the unconventional matrices are more similar to one another. Therefore, they can be subjected to detection using very few standard techniques (especially, LC-MS and GC-MS; see the electronic supplementary material). Below, we provide a brief summary of the characteristics of unconventional human biological matrices obtained in a non-invasive manner. Their composition, origin and functions are summarized. We also discuss the main directions in the research on MS analysis of those matrices, which are related to the fields of clinical analysis, toxicology and forensics. In addition, we summarize the advantages and shortcomings of the analyses of each matrix (see also table 1).
(a). Hair and nail
Hair consists of two parts: hair shaft and hair follicle. The hair shaft is a thin flexible cylindrical structure composed of dead keratinized epithelial cells, while the hair follicle contains living epithelial cells. A blood capillary system surrounds each hair follicle providing necessary nutrients. Hair follicles are directly connected to sebaceous (oil) gland ducts. Each hair shaft consists of three axial layers: medulla (inner layer), cortex (middle layer) and cuticle (outer layer). Hair matrix is composed of proteins (65–95%, mainly keratins), water, lipids and minerals. The average rate of hair growth is approximately 0.4–0.5 mm d–1 [47]. Similar to hair, nails (at the tips of fingers and toes) are composed of a keratinized matrix. Each nail consists of three sections: nail plate, nail matrix and nail bed. The average rate of fingernail growth is estimated to be around 3.0 mm per month, whereas the rate of toenail growth is around 1.1 mm per month [48]. In both hair and nail matrices, keratins form long fibres, which are bound together via disulfide bridges. Those bridges make hair and nail matrices very durable. Various xenobiotic compounds (including drugs) are incorporated into the keratinized matrix. Thus, it is very difficult to alter the chemical compositions of hair and nail specimens.
Owing to the most consistent hair growth being on the vertex of the head, hair specimens are usually collected from this location. Several hair shafts can simply be cut out (as close to the scalp as possible), or they can be plucked out from the scalp (using tweezers) [28,47]. Nail specimens are normally collected by clipping. Both finger nail and toe nail specimens can be collected for chemical analysis. Preparation of hair and nail specimens for analysis includes decontamination, homogenization, extraction/digestion, preconcentration and clean-up [47,49]. The rigid structure of the keratinized matrix can be broken down by overnight alkaline (with NaOH) or acidic (with HCl, H2SO4 or HNO3) digestion. However, following such digestion, some components of interest may be decomposed. Thus, alternative methods of extraction are occasionally implemented; for example, ultrasound-assisted extraction with methanol (after micropulverization of the specimen) [50,51]. To remove matrix interferences (especially after digestion), subsequent clean-up by solid-phase extraction (SPE) is necessary [48]. In fact, such extensive preparation of hair and nail specimens is laborious, time-consuming and may introduce errors to the final result [52]. Less extensive specimen preparation is required for imaging MS—in which case, longitudinally sectioned hair specimens are often used [28]. Hair and nail specimens are very stable. In general, they can be stored and transported at room temperature, while the risk of matrix and analyte degradation is low. Because of the high stability, post-mortem specimens can be collected and analysed [53]. One of the problems related to hair analysis is the fact that dying, bleaching or exposure to heat or sunlight may affect the results [54,55]. Owing to these factors, analytes can decompose, while other chemicals (including drugs of abuse) may adsorb on the hair surface leading to erroneous results [56]. There are also concerns about the rates of analyte incorporation into hair matrix. These rates may depend on the type of hair. For example, some drugs bind to melanin, which contributes to higher concentrations of those drugs in dark hair than in lighter-coloured hair [3]. The advantage of analysis of nails (when compared with hair) is the lack of the possible bias due to different melanin content in the specimens obtained from different individuals [48].
MS analyses of hair specimens include screening for drugs of abuse (cocaine, opiates, amphetamines and cannabinoids) [4,57], pharmaceuticals, stable metabolites of alcohol (fatty acid ethyl esters and ethyl glucuronide) [11] as well as doping agents [26,47]. Analysis of nail specimens can provide complementary information to that obtained from analysis of hair specimens [58,59]. Hair and nail analyses extend the temporal profiling of exposure to xenobiotic substances by up to several months. As a result, chronic abuse of drugs and alcohol or bioaccumulation of environmental contaminants can be verified. Moreover, short-term abstinence can be confirmed [11]. Interestingly, several maxima of a drug concentration in time were observed for the non-benzodiazepine hypnotic drug zolpidem, detected in a nail specimen (following administration of a single dose; figure 2) [17]. The detection window of this drug in the fingernail was appproximately 3.5 months (for further description of this work, see the electronic supplementary material). On the other hand, hair and nail specimens collected within several months after birth can be used as indicators of the exposure to drugs in utero [20]. Moreover, toxic metallic species [60–62], pesticides and persistent organic pollutants [13,51,63] in hair and nail specimens can be investigated. Levels of essential elements in hair and nail are also of interest [15]. In addition, nail specimens are studied to investigate nail disorders, such as fungal infections [29].
Figure 2.
Concentration of the drug zolpidem in fingernail clippings collected from four subjects (a–d) after ingestion of a single dose (10 mg) of zolpidem. Three maxima of the drug concentration in time were observed for most subjects. Peak 1 corresponds to the drug excreted in sweat and sebum, and adsorbed on the nail; peak 2 corresponds to the drug released from the bed of the nail; while peak 3 corresponds to the drug incorporated into the newly formed nail matrix. (Adapted with permission from [17]. Copyright © 2013 Wiley.) (Online version in colour.)
(b). Saliva and nasal mucus
Saliva is viscous oral fluid composed mostly of water (99%). It also contains salts, proteins (enzymes), peptides, hormones, lipids, sugars as well as epithelial cells, food debris and microorganisms. Saliva is secreted primarily by three major salivary glands: the parotid, submaxillary and sublingual glands. The main functions of saliva are: maintenance of the mucosa, involvement in chewing, mineralization of teeth, control of microorganisms, taste perception and digestion [64]. The flow rate of saliva varies from zero to several millilitres per minute, depending on the emotional state and stimulation [65]. Nasal mucus is a gelatinous fluid produced by mucous membranes in the nasal passages. It is composed mostly of water (95%) but it also contains salts, proteins (enzymes) and epithelial cells. Mucus protects the respiratory system by blocking pathogenic antigens and additionally humidifies, cools or heats, and cleans the inhaled air [66].
Relatively large volumes of saliva (more than 1 ml) can be collected directly by expectoration (spitting). Special saliva collectors in the form of an absorbing wipe, pad or sponge can also be implemented [64]. Recently, dried saliva spot [67] and solid-phase microextraction [68] sampling techniques were proposed. Similar to the dried blood spot sampling method, the dried saliva spot sampling method facilitates storage and transport of the specimens from the point of collection to the laboratory. On the other hand, a solid-phase microextraction probe enables in vivo sampling and extraction (due to intrinsic selectivity). Usually, subjects are restricted from eating, drinking or brushing their teeth prior to saliva collection. The advantage of saliva analysis in pharmacokinetic studies is that there is a lower concentration of proteins in saliva than in plasma. Thus, the probability of binding a drug to the proteins is reduced. In consequence, biologically active forms of protein-unbound drugs (or their metabolites) can be quantified. Nonetheless, in the case of some drugs, there are substantial differences between concentrations in saliva and blood [69]. As expected, correlation between saliva and blood concentrations is drug-dependent [64]. Another limitation of saliva analysis is that drugs can be monitored over shorter periods than in the case of urine analysis. Furthermore, this type of specimen can be easily contaminated with food debris. Saliva specimens do not normally require extensive treatment prior to MS analysis. Typically, only solid particles are removed by centrifugation. In several studies, proteins were precipitated with small amounts of an organic solvent prior to analysis of low-molecular-weight drugs [38,70]. In addition, SPE may be performed to preconcentrate and purify the analytes [69]. Nasal mucus can be collected by blowing out the nose over a beaker or by using a swab. Nostrils can be pre-washed with saline solution prior to specimen collection.
Saliva is normally used in the assays targeting drugs of abuse (amphetamines, opioids and cannabis) [71,72], therapeutic drugs [67,70,73], alcohol (ethanol), hormones (cortisol) and steroids [64]. Salivary metabolomics can provide an outlook for diagnosis of oral cancer and periodontal disease [74,75]. In fact, many researchers are interested in the composition of saliva proteome [76]. Saliva can also be analysed to monitor human exposure to toxic elements such as arsenic [77]. MS analysis of nasal mucus has not yet become popular. In one study, volatile organic compounds were analysed in nasal mucus specimens [78]. Some of these compounds were produced by the bacteria causing sinus infections. Nasal mucus can also be used to investigate the exposure of human subjects to air contaminants; for example, traces of cocaine dust in forensic laboratories [79].
(c). Breath
Exhaled breath is composed of water vapour, volatile organic compounds (e.g. metabolites of ingested food and drugs, metabolites produced by bacteria in the gut and airways, or environmental contaminants), inorganic gases (e.g. carbon dioxide and nitric oxide) and non-volatile particles [80]. Breath sampling and analysis can be carried out by several methods. In the first method, the examined subject is normally asked to breathe through a special device comprising a mouthpiece and sorbent for several minutes. The compounds of interest are adsorbed on a sorbent (e.g. solid-phase microextraction sorbent), and later desorbed at an elevated temperature. The second method involves collection of the exhaled breath into a container or a bag with a known volume. The collected breath specimen is then released to the ion source of a mass spectrometer [81]. In the third method, the exhaled breath is condensed in a precooled device, and collected as a liquid sample (the so-called ‘breath condensate’) [82]. Breath sampling can be performed without any restrictions regarding the time and frequency. That point is a big advantage of sampling and analysis of breath specimens.
Breath analysis can be used to monitor compounds of endogenous and exogenous origin, which has already been summarized in numerous review papers [80,83–86]. Potential biomarkers present in exhaled breath can be used for early diagnosis of diseases (especially lung-related) [87,88], and in toxicological investigations (e.g. exposure to tobacco smoke) [83]. Analysis of breath is often used to study the metabolism of administered drugs [81]. The great advantage of breath analysis is the possibility to detect volatile compounds in real time. In one spectacular demonstration, real-time breath sampling, followed by on-line MS analysis, was performed on a patient undergoing surgery [89]. However, when collecting breath specimens, the impact of various contaminants from the environment must be considered because these contaminants may influence the results of breath analysis.
(d). Tears and meibum
Tears are formed from the aqueous fluid that overlays the eye's surface. Tear fluid is composed mostly of water, but also contains lipids, proteins, amino acids, sugars and electrolytes. According to the so-called three-layer model, the tear film consists of an inner mucin layer, a middle aqueous layer and an outer lipid layer [23]. Each of these layers has a different origin—the mucin layer comes from goblet cells, the aqueous layer is secreted by the lacrimal glands, while the lipid layer is mostly produced by meibomian glands. Tears lubricate and hydrate the membranes forming the ocular surface, protect against various pathogens and provide nutrients to the corneal epithelium. Meibum is an oily substance produced by the meibomian glands (type of sebaceous gland) present on the upper and lower eyelids [23,90]. Once secreted, meibum mixes with tears and forms the outer layer of the tear film. The typical total volume of tears present in one eye ranges from approximately 5 to 10 µl, while the secretion rate is of the order of approximately 1.2 µl min−1. Basal tears are composed of the fluid that normally covers the eye's surface, while reflex tears are produced in response to irritation of the eyes by foreign objects [23].
Tears are normally collected using one of the three available methods. In the first method, a 10 μl glass microcapillary is placed very close to the eye without touching the eyeball [91,92]. The second method involves flushing the eye with saline solution, and collecting the after-wash liquid [92]. Notably, in this method, the tear fluid is significantly diluted. The third method implements the so-called Schirmer's strip [92,93]. This can be used to collect tear fluid from subjects with dry-eye syndrome. In this method, a strip of filter paper is placed inside the lower eyelid, and is left there for 5 min to absorb the tear fluid. If basal tears need to be collected, a local anaesthetic may be applied to reduce the release of reflex tears. Afterwards, tear components are extracted from the paper strip using a solvent. Pure meibum specimens can be obtained by applying a small physical force (e.g. by tweezers) to the eyelid, and then collecting the excreted fluid with a spatula. Tear fluid specimens do not normally require extensive sample preparation prior to MS analysis. In many cases, specimens are diluted with organic solvents, and solid particles are removed by centrifugation. According to the Folch method [94], lipids can be extracted from tears and meibum using biphasic extraction (with a mixture of chloroform and methanol, followed by addition of a buffer) [95].
Tear fluid is used to investigate various ocular diseases, including dry-eye syndrome [96]. Numerous reports focus on lipidomic analyses of human tear and meibum [90]. Some of the recent studies have demonstrated major differences in the lipid composition of tear fluid and meibum fluid [92,97]. Moreover, other endogenous metabolites, such as amino acids or glucose, can be detected in tear fluid by means of MS [91,98]. Protein content as well as the presence of therapeutic drugs in eye-derived specimens are also of great interest [43,99].
(e). Skin excretions
Human skin is coated with a film containing numerous compounds, which can altogether be regarded as ‘skin excretions’. Some of these compounds are secreted by specialized glands (predominantly, eccrine (sweat) and sebaceous (oil) glands), while others are produced during the breakdown of proteins in the outermost layer of the skin [100]. Sweat fluid is mostly composed of water. However, it also contains mineral elements (e.g. sodium and potassium) and organic compounds such as proteins, amino acids, lactic acid and urea [101,102]. The typical sweating rate (without stimulation) ranges from approximately 300 to 700 ml d–1 [3]. Sebum is an oily substance mostly composed of lipids. In fact, different compounds present on the skin surface have diverse distributions (influenced by skin cells, microbes and daily routines) [103]. The main function of sweating is to protect the human body from overheating. Skin excretions (including sweat) also moisturize the skin, and protect it from evaporation of water.
It is difficult to collect pure sweat, separately from other skin excretions. Thus, usually a mixture of all skin excretions, lifted from the skin, is analysed. However, in many reports, this mixture is inaccurately referred to as ‘sweat’. One standardized method of pharmacological stimulation of sweating is used to collect sufficient volumes of sweat-rich fluid (more than 50 µl) [35]. As we mentioned earlier, at first, sweating is induced by pilocarpine iontophoresis. Then, the so-called Macroduct is employed to collect sweat. Smaller volumes of sweat and skin excretions can be collected using various accessories, such as a semipermeable skin patch (the most widely used), cotton swab, cellulose wipe, textile [104], silica plate [105] or hydrogel micropatch [106]. A skin patch can be worn for up to a fortnight, while other collectors are suitable for sampling during short periods of time. Subsequently, skin excretions are extracted from the collector off-line using a solvent. Nonetheless, an on-line extraction method has also been demonstrated [106,107]. In this approach, endogenous metabolites collected with the use of hydrogel micropatches (figure 3) were extracted on-line, and subsequently ionized at atmospheric pressure (for further description of this work, see the electronic supplementary material). Skin excretions do not normally require extensive sample preparation prior to MS analysis. Usually, specimens are diluted with an organic solvent, followed by the removal of solid particles by centrifugation. However, a high content of salts present in the sweat (which cannot be removed by centrifugation) may contribute to ion suppression during MS analysis. This is one of the main disadvantages of using skin excretion specimens in clinical assays.
Figure 3.
Sampling and rapid chemical profiling of skin metabolites collected using a hydrogel micropatch probe. The probe was attached to the skin for 10 min. Subsequently, it was analysed by nanospray DESI-MS without further treatment. Numerous metabolite species were detected. (Adapted with permission from [106]. Copyright (2014) American Chemical Society.) (Online version in colour.)
Skin excretions are used to conduct tests for drugs of abuse (amphetamines, cannabis, cocaine and opiates) [104], therapeutic drugs [108] and other xenobiotics [109,110], such as nicotine or caffeine [111,112]. The advantage of skin excretion analysis in drug testing is that non-metabolized drugs are likely to be excreted with sweat and sebum. This characteristic makes identification of an excreted drug simpler. Endogenous metabolites excreted by skin may serve as important biomarkers of disease [105,113,114]. Volatile organic compounds emanating from skin, such as alcohols, fatty acids or esters, are also of great interest [115,116]. In the area of forensic science, attention is paid to chemical analysis of latent fingerprints [117].
4. Conclusion and future trends
The areas of application of mass spectrometric analysis of unconventional biological specimens include clinical analysis, toxicology and forensics. There has been enormous progress in the development of analytical methods targeting unconventional biological specimens. However, many of the published protocols are based on very few instrumental platforms, such as LC-ESI-MS and GC-EI-MS. Certainly, these instruments are adequate for performing quantitative analyses. Nonetheless, they provide limited analytical throughput because chromatographic separation takes from a few minutes to several tens of minutes. Thus, direct mass spectrometric approaches—without the separation step—have been proposed. Further development of these methods will certainly be directed towards the implementation of portable mass spectrometers in the analysis of unconventional specimens at the points of specimen collection. Nevertheless, adoption of such approaches has to be preceded by comprehensive tests focused on technical quality.
MS is particularly vulnerable to matrix effects (ion suppression). Thus, variable chemical composition of biological specimens may considerably affect the analysis results if the separation step is missing. Another obstacle in the implementation of unconventional biological specimens in routine analysis is sample pre-treatment. Such specimens are composed of numerous biomolecules with diverse physical and chemical properties. Their extractability may be limited by the intrinsic structure of the matrix. Hence, there is a need to develop efficient methods of extraction and concentration of trace molecules of interest. Protocols for handling and detecting multiple analytes at once are desired. Moreover, normalization of the amounts of the collected specimens (e.g. breath, tears and sweat), for absolute quantification, is still problematic. Because of the inter-personal variability (e.g. related to rate of perspiration, mucus secretion, breath volume), it is necessary to standardize the specimen collection protocols. In addition, the metabolites that have equal concentrations across the studied groups of subjects may be used for normalization. Further work in this direction is required. Above all, the biggest shortcomings of the available analytical toolkit include the lack of harmonization of different steps (including sample pre-treatment, separation and detection) as well as validation of the developed procedures. These shortcomings are the main reasons for the limited use of unconventional human biological matrices in the clinical setting. One can envision that, in future, several specimens (e.g. hair, nails, breath or skin excretion) will be obtained from a patient to be diagnosed. Subsequently, multiple assays will be performed to produce a comprehensive report on the patient's health.
Supplementary Material
Data accessibility
The section ‘Procedures and applications’ has been included in the electronic supplementary material.
Authors' contributions
E.P.D. conducted literature survey and drafted the manuscript. P.L.U. critically discussed the content and edited the manuscript draft. Both authors gave final approval of the version to be published.
Competing interests
We have no competing interests.
Funding
E.P.D.: National Chiao Tung University (PhD scholarship). P.L.U.: Ministry of Science and Technology of Taiwan (grant no. MOST 104-2628-M-009-003-MY4) and National Chiao Tung University (intramural grant).
References
- 1.Lozano J, García-Algar O, Vall O, de la Torre R, Scaravelli G, Pichini S. 2007. Biological matrices for the evaluation of in utero exposure to drugs of abuse. Ther. Drug Monit. 29, 711–734. ( 10.1097/FTD.0b013e31815c14ce) [DOI] [PubMed] [Google Scholar]
- 2.Patteet L, Cappelle D, Maudens KE, Crunelle CL, Sabbe B, Neels H. 2015. Advances in detection of antipsychotics in biological matrices. Clin. Chim. Acta 441, 11–22. ( 10.1016/j.cca.2014.12.008) [DOI] [PubMed] [Google Scholar]
- 3.Gallardo E, Queiroz JA. 2008. The role of alternative specimens in toxicological analysis. Biomed. Chromatogr. 22, 795–821. ( 10.1002/bmc.1009) [DOI] [PubMed] [Google Scholar]
- 4.Vincenti M, Salomone A, Gerace E, Pirro V. 2013. Application of mass spectrometry to hair analysis for forensic toxicological investigations. Mass Spectrom. Rev. 32, 312–332. ( 10.1002/mas.21364) [DOI] [PubMed] [Google Scholar]
- 5.Chace DH. 2001. Mass spectrometry in the clinical laboratory. Chem. Rev. 101, 445–477. ( 10.1021/cr990077%2B) [DOI] [PubMed] [Google Scholar]
- 6.Kandiah M, Urban PL. 2013. Advances in ultrasensitive mass spectrometry of organic molecules. Chem. Soc. Rev. 42, 5299–5322. ( 10.1039/c3cs35389c) [DOI] [PubMed] [Google Scholar]
- 7.Chen P, Chakraborty S, Mukhopadhyay S, Lee E, Paoliello MMB, Bowman AB, Aschner M. 2015. Manganese homeostasis in the nervous system. J. Neurochem. 134, 601–610. ( 10.1111/jnc.13170) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Nicholson JK, Lindon JC. 2008. Systems biology: metabonomics. Nature 455, 1054–1056. ( 10.1038/4551054a) [DOI] [PubMed] [Google Scholar]
- 9.Barroso M, Gallardo E, Vieira DN, Queiroz JA, López-Rivadulla M. 2011. Bioanalytical procedures and recent developments in the determination of opiates/opioids in human biological samples. Anal. Boanalytical Chem. 400, 1665–1690. ( 10.1007/s00216-011-4888-4) [DOI] [PubMed] [Google Scholar]
- 10.Znaleziona J, Ginterová P, Petr J, Ondra P, Válka I, Ševčík J, Chrastina J, Maier V. 2015. Determination and identification of synthetic cannabinoids and their metabolites in different matrices by modern analytical techniques—a review. Anal. Chim. Acta 874, 11–25. ( 10.1016/j.aca.2014.12.055) [DOI] [PubMed] [Google Scholar]
- 11.Crunelle CL, et al. 2014. Hair ethyl glucuronide levels as a marker for alcohol use and abuse: a review of the current state of the art. Drug Alcohol Depend. 134, 1–11. ( 10.1016/j.drugalcdep.2013.10.008) [DOI] [PubMed] [Google Scholar]
- 12.Gosetti F, Mazzucco E, Gennaro MC, Marengo E. 2013. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices: a review. J. Chromatogr. B 927, 22–36. ( 10.1016/j.jchromb.2012.12.003) [DOI] [PubMed] [Google Scholar]
- 13.Tsatsakis A, Tutudaki M. 2004. Progress in pesticide and POPs hair analysis for the assessment of exposure. Forensic Sci. Int. 145, 195–199. ( 10.1016/j.forsciint.2004.04.036) [DOI] [PubMed] [Google Scholar]
- 14.Esteban M, Castaño A. 2009. Non-invasive matrices in human biomonitoring: a review. Environ. Int. 35, 438–449. ( 10.1016/j.envint.2008.09.003) [DOI] [PubMed] [Google Scholar]
- 15.Golasik M, Jawień W, Przybyłowicz A, Szyfter W, Herman M, Golusiński W, Florek E, Piekoszewski W. 2015. Classification models based on the level of metals in hair and nails of laryngeal cancer patients: diagnosis support or rather speculation? Metallomics 7, 455–465. ( 10.1039/C4MT00285G) [DOI] [PubMed] [Google Scholar]
- 16.Palmeri A, Pichini S, Pacifici R, Zuccaro P, Lopez A. 2000. Drugs in nails. Physiology, pharmacokinetics and forensic toxicology. Clin. Pharmacokinet. 38, 95–110. ( 10.2165/00003088-200038020-00001) [DOI] [PubMed] [Google Scholar]
- 17.Madry MM, Steuer AE, Binz TM, Baumgartner MR, Kraemer T. 2013. Systematic investigation of the incorporation mechanisms of zolpidem in fingernails. Drug Test. Anal. 6, 533–541. ( 10.1002/dta.1558) [DOI] [PubMed] [Google Scholar]
- 18.Chèze M, Duffort G, Deveaux M, Pépin G. 2005. Hair analysis by liquid chromatography—tandem mass spectrometry in toxicological investigation of drug-facilitated crimes: report of 128 cases over the period June 2003–May 2004 in metropolitan Paris. Forensic Sci. Int. 153, 3–10. ( 10.1016/j.forsciint.2005.04.021) [DOI] [PubMed] [Google Scholar]
- 19.Tegethoff M, Raul J-S, Jamey C, Khelil MB, Ludes B, Meinlschmidt G. 2011. Dehydroepiandrosterone in nails of infants: a potential biomarker of intrauterine responses to maternal stress. Biol. Psychol. 87, 414–420. ( 10.1016/j.biopsycho.2011.05.007) [DOI] [PubMed] [Google Scholar]
- 20.Mari F, Politi L, Bertol E. 2008. Nails of newborns in monitoring drug exposure during pregnancy. Forensic Sci. Int. 179, 176–180. ( 10.1016/j.forsciint.2008.06.001) [DOI] [PubMed] [Google Scholar]
- 21.Morini L, et al. 2013. Testing ethylglucuronide in maternal hair and nails for the assessment of fetal exposure to alcohol: comparison with meconium testing. Ther. Drug Monit. 35, 402–407. ( 10.1097/FTD.0b013e318283f719) [DOI] [PubMed] [Google Scholar]
- 22.Milman G, Barnes AJ, Lowe RH, Huestis MA. 2010. Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry. J. Chromatogr. A 1217, 1513–1521. ( 10.1016/j.chroma.2009.12.053) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Zhou L, Beuerman RW. 2012. Tear analysis in ocular surface diseases. Prog. Retin. Eye Res. 31, 527–550. ( 10.1016/j.preteyeres.2012.06.002) [DOI] [PubMed] [Google Scholar]
- 24.National Institute for Environmental Studies, Japan. No. 13 Human hair. NIES CRMs. See http://www.nies.go.jp/labo/crm-e/hair.html.
- 25.Sigma-Aldrich. 2016. Human hair (trace elements). ERM® certified Reference Material. See http://www.sigmaaldrich.com/catalog/product/sial/ermdb001?lang=en®ion=TW.
- 26.Society of Hair Testing. See http://www.soht.org/.
- 27.Kintz P, Ginet M, Cirimele V. 2006. Multi-element screening by ICP-MS of two specimens of Napoleon's hair. J. Anal. Toxicol. 30, 621–623. ( 10.1093/jat/30.8.621) [DOI] [PubMed] [Google Scholar]
- 28.Kamata T, et al. 2015. Time-course mass spectrometry imaging for depicting drug incorporation into hair. Anal. Chem. 87, 5476–5481. ( 10.1021/acs.analchem.5b00971) [DOI] [PubMed] [Google Scholar]
- 29.Pföhler C, Hollemeyer K, Heinzle E, Altmeyer W, Graeber S, Müller CSL, Stark A, Jager SU, Tilgen W. 2009. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: a new tool in diagnostic investigation of nail disorders? Exp. Dermatol. 18, 880–882. ( 10.1111/j.1600-0625.2008.00838.x) [DOI] [PubMed] [Google Scholar]
- 30.Takáts Z, Wiseman JM, Gologan B, Cooks RG. 2004. Mass spectrometry sampling under ambient conditions with desorption electrospray ionization. Science. 306, 471–473. ( 10.1126/science.1104404) [DOI] [PubMed] [Google Scholar]
- 31.Harrison GR, Critchley ADJ, Mayhew CA, Thompson JM. 2003. Real-time breath monitoring of propofol and its volatile metabolites during surgery using a novel mass spectrometric technique: a feasibility study. Br. J. Anaesth. 91, 797–799. ( 10.1093/bja/aeg271) [DOI] [PubMed] [Google Scholar]
- 32.Fraser I, Meier-Augenstein W, Kalin RM. 2006. The role of stable isotopes in human identification: a longitudinal study into the variability of isotopic signals in human hair and nails. Rapid Commun. Mass Spectrom. 20, 1109–1116. ( 10.1002/rcm.2424) [DOI] [PubMed] [Google Scholar]
- 33.Fransson MN, Rial-Sebbag E, Brochhausen M, Litton J-E. 2014. Toward a common language for biobanking. Eur. J. Hum. Genet. 23, 1–7. ( 10.1038/ejhg.2014.45) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.IUPAC. IUPAC Compendium of Chemical Terminology—the Gold Book. See http://goldbook.iupac.org/.
- 35.Green A, Kirk J. 2007. Guidelines for the performance of the sweat test for the diagnosis of cystic fibrosis. Ann. Clin. Biochem. 44, 25–34. ( 10.1258/000456307779596011) [DOI] [PubMed] [Google Scholar]
- 36.Gibson LE, Cooke RE. 1959. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 23, 545–549. [PubMed] [Google Scholar]
- 37.Correa DN, Santos JM, Teunissen SF, Eberlin LS, Eberlin MN. 2016. Forensic chemistry and ambient mass spectrometry: a perfect couple destined for a happy marriage? Anal. Chem. 88, 2515–2526. ( 10.1021/acs.analchem.5b02397) [DOI] [PubMed] [Google Scholar]
- 38.Yamada E, Takagi R, Sudo K, Kato S. 2015. Determination of abacavir, tenofovir, darunavir, and raltegravir in human plasma and saliva using liquid chromatography coupled with tandem mass spectrometry. J. Pharm. Biomed. Anal. 114, 390–397. ( 10.1016/j.jpba.2015.06.005) [DOI] [PubMed] [Google Scholar]
- 39.Arafat T, Arafat B, Abu A. 2014. Determination of loperamide in human plasma and saliva by liquid chromatography—tandem mass spectrometry. J. Chromatogr. B 972, 81–88. ( 10.1016/j.jchromb.2014.09.037) [DOI] [PubMed] [Google Scholar]
- 40.Urban PL, Chen Y-C, Wang Y-S. 2016. Time-resolved mass spectrometry: from concept to applications. Chichester, UK: Wiley Online Library. [Google Scholar]
- 41.European Medicines Agency (EMA), Committee for Medicinal Products for Human Use (CHMP). 2011. Guideline on bioanalytical method validation. See http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf.
- 42.U.S. Department of Health and Human Services Food and Drug Administration. 2013. Guidance for industry: bioanalytical method validation. See http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm368107.pdf.
- 43.Hirosawa M, Sambe T, Uchida N, Lee X-P, Sato K, Kobayashi S. 2015. Determination of nonsteroidal anti-inflammatory drugs in human tear and plasma samples using ultra-fast liquid chromatography-tandem mass spectrometry. Jpn. J. Ophthalmol. 59, 364–371. ( 10.1007/s10384-015-0389-x) [DOI] [PubMed] [Google Scholar]
- 44.Concheiro M, Shakleya DM, Huestis MA. 2011. Simultaneous analysis of buprenorphine, methadone, cocaine, opiates and nicotine metabolites in sweat by liquid chromatography tandem mass spectrometry. Anal. Bioanal. Chem. 400, 69–78. ( 10.1007/s00216-010-4392-2) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Shi Y, Liu X, Zhang J, Shao B. 2013. Analysis of triclosan and triclocarban in human nails using isotopic dilution liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 934, 97–101. ( 10.1016/j.jchromb.2013.07.003) [DOI] [PubMed] [Google Scholar]
- 46.Rodushkin I, Axelsson MD. 2003. Application of double focusing sector field ICP-MS for multielemental characterization of human hair and nails. III. Direct analysis by laser ablation. Sci. Total Environ. 305, 23–39. ( 10.1016/S0048-9697(02)00463-1) [DOI] [PubMed] [Google Scholar]
- 47.Boumba VA, Ziavrou KS, Vougiouklakis T. 2006. Hair as a biological indicator of drug use, drug abuse or chronic exposure to environmental toxicants. Int. J. Toxicol. 25, 143–163. ( 10.1080/10915810600683028) [DOI] [PubMed] [Google Scholar]
- 48.Cappelle D, Yegles M, Neels H, van Nuijs ALN, De Doncker M, Maudens K, Covaci A, Crunelle CL. 2015. Nail analysis for the detection of drugs of abuse and pharmaceuticals: a review. Forensic Toxicol. 33, 12–36. ( 10.1007/s11419-014-0258-1) [DOI] [Google Scholar]
- 49.Vogliardi S, Tucci M, Stocchero G, Ferrara SD, Favretto D. 2015. Sample preparation methods for determination of drugs of abuse in hair samples: a review. Anal. Chim. Acta 857, 1–27. ( 10.1016/j.aca.2014.06.053) [DOI] [PubMed] [Google Scholar]
- 50.Kim JY, Cheong JC, Lee J, Son JH, In MK. 2012. Rapid and simple GC-MS method for determination of psychotropic phenylalkylamine derivatives in nails using micro-pulverized extraction. J. Forensic Sci. 57, 228–233. ( 10.1111/j.1556-4029.2011.01913.x) [DOI] [PubMed] [Google Scholar]
- 51.Li J, Guo F, Wang Y, Liu J, Cai Z, Zhang J, Zhao Y, Wu Y. 2012. Development of extraction methods for the analysis of perfluorinated compounds in human hair and nail by high performance liquid chromatography tandem mass spectrometry. J. Chromatogr. A 1219, 54–60. ( 10.1016/j.chroma.2011.11.015) [DOI] [PubMed] [Google Scholar]
- 52.Musshoff F, Madea B. 2007. New trends in hair analysis and scientific demands on validation and technical notes. Forensic Sci. Int. 165, 204–215. ( 10.1016/j.forsciint.2006.05.024) [DOI] [PubMed] [Google Scholar]
- 53.Engelhart DA, Jenkins AJ. 2002. Detection of cocaine analytes and opiates in nails from postmortem cases. J. Anal. Toxicol. 26, 489–492. ( 10.1093/jat/26.7.489) [DOI] [PubMed] [Google Scholar]
- 54.Cuypers E, Flinders B, Bosman IJ, Lusthof KJ, Van Asten AC, Tytgat J, Heeren RMA. 2014. Hydrogen peroxide reactions on cocaine in hair using imaging mass spectrometry. Forensic Sci. Int. 242, 103–110. ( 10.1016/j.forsciint.2014.06.035) [DOI] [PubMed] [Google Scholar]
- 55.Ettlinger J, Kirchen L, Yegles M. 2014. Influence of thermal hair straightening on ethyl glucuronide content in hair. Drug Test. Anal. 6, 74–77. ( 10.1002/dta.1648) [DOI] [PubMed] [Google Scholar]
- 56.LeBeau MA, Montgomery MA. 2009. Considerations on the utility of hair analysis for cocaine. J. Anal. Toxicol. 33, 343–344. ( 10.1093/jat/33.6.343) [DOI] [PubMed] [Google Scholar]
- 57.Baciu T, Borrull F, Aguilar C, Calull M. 2015. Recent trends in analytical methods and separation techniques for drugs of abuse in hair. Anal. Chim. Acta 856, 1–26. ( 10.1016/j.aca.2014.06.051) [DOI] [PubMed] [Google Scholar]
- 58.Krumbiegel F, Hastedt M, Tsokos M. 2014. Nails are a potential alternative matrix to hair for drug analysis in general unknown screenings by liquid-chromatography quadrupole time-of-flight mass spectrometry. Forensic Sci. Med. Pathol. 10, 496–503. ( 10.1007/s12024-014-9588-x) [DOI] [PubMed] [Google Scholar]
- 59.Shen M, Chen H, Xiang P. 2014. Determination of opiates in human fingernail — comparison to hair. J. Chromatogr. B 967, 84–89. ( 10.1016/j.jchromb.2014.07.014) [DOI] [PubMed] [Google Scholar]
- 60.Samanta G, Sharma R, Roychowdhury T, Chakraborti D. 2004. Arsenic and other elements in hair, nails, and skin-scales of arsenic victims in West Bengal, India. Sci. Total Environ. 326, 33–47. ( 10.1016/j.scitotenv.2003.12.006) [DOI] [PubMed] [Google Scholar]
- 61.Batista BL, Rodrigues JL, Nunes JA, Tormen L, Curtius AJ, Barbosa F. 2008. Simultaneous determination of Cd, Cu, Mn, Ni, Pb and Zn in nail samples by inductively coupled plasma mass spectrometry (ICP-MS) after tetramethylammonium hydroxide solubilization at room temperature: comparison with ETAAS. Talanta 76, 575–579. ( 10.1016/j.talanta.2008.03.046) [DOI] [PubMed] [Google Scholar]
- 62.Krystek P, Favaro P, Bode P, Ritsema R. 2012. Methyl mercury in nail clippings in relation to fish consumption analysis with gas chromatography coupled to inductively coupled plasma mass spectrometry: a first orientation. Talanta 97, 83–86. ( 10.1016/j.talanta.2012.03.065) [DOI] [PubMed] [Google Scholar]
- 63.Liu W, Xu L, Li X, Jin YH, Sasaki K, Saito N, Sato I, Tsuda S. 2011. Human nails analysis as biomarker of exposure to perfluoroalkyl compounds. Environ. Sci. Technol. 45, 8144–8150. ( 10.1021/es1036207) [DOI] [PubMed] [Google Scholar]
- 64.Drummer OH. 2006. Drug testing in oral fluid. Clin. Biochem. Rev. 27, 147–159. [PMC free article] [PubMed] [Google Scholar]
- 65.Nunes LAS, Mussavira S, Bindhu OS. 2015. Clinical and diagnostic utility of saliva as a non-invasive diagnostic fluid: a systematic review. Biochem. Med. 25, 177–192. ( 10.11613/BM.2015.018) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Quraishi MS, Jones NS, Mason J. 1998. The theology of nasal mucus: a review. Clin. Otolaryngol. Allied Sci. 23, 403–413. ( 10.1046/j.1365-2273.1998.00172.x) [DOI] [PubMed] [Google Scholar]
- 67.Abdel-Rehim A, Abdel-Rehim M. 2014. Dried saliva spot as a sampling technique for saliva samples. Biomed. Chromatogr. 28, 875–877. ( 10.1002/bmc.3193) [DOI] [PubMed] [Google Scholar]
- 68.Bessonneau V, Boyaci E, Maciazek-Jurczyk M, Pawliszyn J. 2015. In vivo solid phase microextraction sampling of human saliva for non-invasive and on-site monitoring. Anal. Chim. Acta 856, 35–45. ( 10.1016/j.aca.2014.11.029) [DOI] [PubMed] [Google Scholar]
- 69.Burckhardt BB, Tins J, Laeer S. 2014. Liquid chromatography-tandem mass spectrometry method for determination of aliskiren in saliva and its application to a clinical trial with healthy volunteers. J. Pharm. Biomed. Anal. 96, 118–126. ( 10.1016/j.jpba.2014.03.021) [DOI] [PubMed] [Google Scholar]
- 70.Idkaidek N, Arafat T. 2012. Saliva versus plasma pharmacokinetics: theory and application of a salivary excretion classification system. Mol. Pharm. 9, 2358–2363. ( 10.1021/mp300250r) [DOI] [PubMed] [Google Scholar]
- 71.Schramm W, Smith RH, Craig PA, Kidwell DA. 1992. Drugs of abuse in saliva: a review. J. Anal. Toxicol. 16, 1–9. ( 10.1093/jat/16.1.1) [DOI] [PubMed] [Google Scholar]
- 72.Lee D, Huestis MA. 2014. Current knowledge on cannabinoids in oral fluid. Drug Test. Anal. 6, 88–111. ( 10.1002/dta.1514) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Ogawa S, Tadokoro H, Sato M, Higashi T. 2014. Enantioselective determination of ibuprofen in saliva by liquid chromatography/tandem mass spectrometry with chiral electrospray ionization-enhancing and stable isotope-coded derivatization. J. Pharm. Biomed. Anal. 98, 387–392. ( 10.1016/j.jpba.2014.06.024) [DOI] [PubMed] [Google Scholar]
- 74.Mikkonen JJW, Singh SP, Herrala M, Lappalainen R, Myllymaa S, Kullaa AM. 2015. Salivary metabolomics in the diagnosis of oral cancer and periodontal diseases. J. Periodontal Res. 51, 431–437 ( 10.1111/jre.12327) [DOI] [PubMed] [Google Scholar]
- 75.Bregy L, Müggler AR, Martinez-Lozano Sinues P, García-Gómez D, Suter Y, Belibasakis GN, Kohler M, Schmidlin PR, Zenobi R. 2015. Differentiation of oral bacteria in in vitro cultures and human saliva by secondary electrospray ionization-mass spectrometry. Sci. Rep. 5, 15163 ( 10.1038/srep15163) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Hu S, Loo JA, Wong DT. 2007. Human saliva proteome analysis. Ann. N. Y. Acad. Sci. 1098, 323–329. ( 10.1196/annals.1384.015) [DOI] [PubMed] [Google Scholar]
- 77.Yuan C, Lu X, Oro N, Wang Z, Xia Y, Wade TJ, Mumford J, Le XC. 2008. Arsenic speciation analysis in human saliva. Clin. Chem. 54, 163–171. ( 10.1373/clinchem.2007.092189) [DOI] [PubMed] [Google Scholar]
- 78.Preti G, Thaler E, Hanson CW, Troy M, Eades J, Gelperin A. 2009. Volatile compounds characteristic of sinus-related bacteria and infected sinus mucus: analysis by solid-phase microextraction and gas chromatography-mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 877, 2011–2018. ( 10.1016/j.jchromb.2009.05.028) [DOI] [PubMed] [Google Scholar]
- 79.Armenta S, De La Guardia M, Alcala M, Blanco M, Perez-Alfonso C, Galipienso N. 2014. Ion mobility spectrometry evaluation of cocaine occupational exposure in forensic laboratories. Talanta 130, 251–258. ( 10.1016/j.talanta.2014.06.044) [DOI] [PubMed] [Google Scholar]
- 80.Manolis A. 1983. The diagnostic potential of breath analysis. Clin. Chem. 29, 5–15. [PubMed] [Google Scholar]
- 81.Berchtold C, Bosilkovska M, Daali Y, Walder B, Zenobi R. 2014. Real-time monitoring of exhaled drugs by mass spectrometry. Mass Spectrom. Rev. 33, 394–413. ( 10.1002/mas.21393) [DOI] [PubMed] [Google Scholar]
- 82.Kubáň P, Foret F. 2013. Exhaled breath condensate: determination of non-volatile compounds and their potential for clinical diagnosis and monitoring: a review. Anal. Chim. Acta 805, 1–18. ( 10.1016/j.aca.2013.07.049) [DOI] [PubMed] [Google Scholar]
- 83.Amann A, Miekisch W, Schubert J, Buszewski B, Ligor T, Jezierski T, Pleil J, Risby T. 2014. Analysis of exhaled breath for disease detection. Annu. Rev. Anal. Chem. (Palo Alto. Calif). 7, 455–482. ( 10.1146/annurev-anchem-071213-020043) [DOI] [PubMed] [Google Scholar]
- 84.Smith D, Španěl P, Herbig J, Beauchamp J. 2014. Mass spectrometry for real-time quantitative breath analysis. J. Breath Res. 8, 027101 ( 10.1088/1752-7155/8/2/027101) [DOI] [PubMed] [Google Scholar]
- 85.Beck O, Olin A-C, Mirgorodskaya E. 2016. Potential of mass spectrometry in developing clinical laboratory biomarkers of nonvolatiles in exhaled breath. Clin. Chem. 62, 84–91. ( 10.1373/clinchem.2015.239285) [DOI] [PubMed] [Google Scholar]
- 86.Peralbo-Molina A, Calderón-Santiago M, Priego-Capote F, Jurado-Gámez B, Luque de Castro MD. 2015. Development of a method for metabolomic analysis of human exhaled breath condensate by gas chromatography-mass spectrometry in high resolution mode. Anal. Chim. Acta 887, 118–126. ( 10.1016/j.aca.2015.07.008) [DOI] [PubMed] [Google Scholar]
- 87.Badjagbo K. 2012. Exhaled breath analysis for early cancer detection: principle and progress in direct mass spectrometry techniques. Clin. Chem. Lab. Med. 50, 1893–1902. ( 10.1515/cclm-2012-0208) [DOI] [PubMed] [Google Scholar]
- 88.Pan S, et al. 2015. Quantitative detection of nitric oxide in exhaled human breath by extractive electrospray ionization mass spectrometry. Sci. Rep. 5, 8725 ( 10.1038/srep08725) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Trefz P, et al. 2013. Continuous real time breath gas monitoring in the clinical environment by proton-transfer-reaction-time of flight-mass spectrometry. Anal. Chem. 85, 10 321–10 329. ( 10.1021/ac402298v) [DOI] [PubMed] [Google Scholar]
- 90.Butovich IA. 2013. Tear film lipids. Exp. Eye Res. 117, 4–27. ( 10.1016/j.exer.2013.05.010) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Taormina CR, Baca JT, Asher SA, Grabowski JJ, Finegold DN. 2007. Analysis of tear glucose concentration with electrospray ionization mass spectrometry. J. Am. Soc. Mass Spectrom. 18, 332–336. ( 10.1016/j.jasms.2006.10.002) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Lam SM, Tong L, Duan X, Petznick A, Wenk MR, Shui G. 2014. Extensive characterization of human tear fluid collected using different techniques unravels the presence of novel lipid amphiphiles. J. Lipid Res. 55, 289–298. ( 10.1194/jlr.M044826) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Nakajima M, et al. 2000. Assessment of drug concentrations in tears in therapeutic drug monitoring: I. Determination of valproic acid in tears by gas chromatography/mass spectrometry with EC/NCI mode. Ther. Drug Monit. 22, 716–722. ( 10.1097/00007691-200012000-00011) [DOI] [PubMed] [Google Scholar]
- 94.Folch J, Lees M, Sloane Stanley GH. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Bol. Chem. 226, 497–509. [PubMed] [Google Scholar]
- 95.Saville JT, Zhao Z, Willcox MDP, Ariyavidana MA, Blanksby SJ, Mitchell TW. 2011. Identification of phospholipids in human meibum by nano-electrospray ionisation tandem mass spectrometry. Exp. Eye Res. 92, 238–240. ( 10.1016/j.exer.2010.12.012) [DOI] [PubMed] [Google Scholar]
- 96.Jacob JT, Ham B. 2008. Compositional profiling and biomarker identification of the tear film. Ocul. Surf. 6, 175–185. ( 10.1016/S1542-0124(12)70178-7) [DOI] [PubMed] [Google Scholar]
- 97.Rohit A, Stapleton F, Brown SHJ, Mitchell TW, Willcox MDP. 2014. Comparison of tear lipid profile among basal, reflex, and flush tear samples. Optom. Vis. Sci. 91, 1391–1395. ( 10.1097/OPX.0000000000000411) [DOI] [PubMed] [Google Scholar]
- 98.Chen L, Zhou L, Chan ECY, Neo J, Beuerman RW. 2011. Characterization of the human tear metabolome by LC-MS/MS. J. Proteome Res. 10, 4876–4882. ( 10.1021/pr2004874) [DOI] [PubMed] [Google Scholar]
- 99.von Thun und Hohenstein-Blaul N, Funke S, Grus FH. 2013. Tears as a source of biomarkers for ocular and systemic diseases. Exp. Eye Res. 117, 126–137. ( 10.1016/j.exer.2013.07.015) [DOI] [PubMed] [Google Scholar]
- 100.Brown SJ, Irwin McLean WH. 2012. One remarkable molecule: filaggrin. J. Invest. Dermatol. 132, 751–762. ( 10.1038/jid.2011.393) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Calderón-Santiago M, Priego-Capote F, Jurado-Gámez B, Luque de Castro MD. 2014. Optimization study for metabolomics analysis of human sweat by liquid chromatography-tandem mass spectrometry in high resolution mode. J. Chromatogr. A 1333, 70–78. ( 10.1016/j.chroma.2014.01.071) [DOI] [PubMed] [Google Scholar]
- 102.Delgado-Povedano MM, Calderón-Santiago M, Priego-Capote F, Jurado-Gámez B, Luque de Castro MD. 2016. Development of a method for metabolomic analysis of human exhaled breath condensate by gas chromatography–mass spectrometry in high resolution mode. Anal. Chim. Acta 905, 115–125. ( 10.1016/j.aca.2015.11.048) [DOI] [PubMed] [Google Scholar]
- 103.Bouslimani A, et al. 2015. Molecular cartography of the human skin surface in 3D. Proc. Natl Acad. Sci. USA 112, E2120–E2129. ( 10.1073/pnas.1424409112) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.De Giovanni N, Fucci N. 2013. The current status of sweat testing for drugs of abuse: a review. Curr. Med. Chem. 20, 545–561. ( 10.2174/0929867311320040006) [DOI] [PubMed] [Google Scholar]
- 105.Lima E, de Macedo CS, Esteves CZ, de Oliveira DN, Pessolani MCV, Nery JAC, Sarno EN, Catharino RR. 2015. Skin imprinting in silica plates: a potential diagnostic methodology for leprosy using high-resolution mass spectrometry. Anal. Chem. 87, 3585–3592. ( 10.1021/acs.analchem.5b00097) [DOI] [PubMed] [Google Scholar]
- 106.Dutkiewicz EP, Lin J-D, Tseng T-W, Wang Y-S, Urban PL. 2014. Hydrogel micropatches for sampling and profiling skin metabolites. Anal. Chem. 86, 2337–2344. ( 10.1021/ac4039338) [DOI] [PubMed] [Google Scholar]
- 107.Dutkiewicz EP, Chiu H-Y, Urban PL. 2015. Micropatch-arrayed pads for non-invasive spatial and temporal profiling of topical drugs on skin surface. J. Mass Spectrom. 50, 1321–1325. ( 10.1002/jms.3702) [DOI] [PubMed] [Google Scholar]
- 108.Lankheet NAG, Blank CU, Mallo H, Adriaansz S, Rosing H, Schellens JHM, Huitema ADR, Beijnen JH. 2011. Determination of sunitinib and its active metabolite N-desethylsunitinib in sweat of a patient. J. Anal. Toxicol. 35, 558–565. ( 10.1093/anatox/35.8.558) [DOI] [PubMed] [Google Scholar]
- 109.Kintz P, Henrich A, Cirimele V, Ludes B. 1998. Nicotine monitoring in sweat with a sweat patch. J. Chromatogr. B Biomed. Appl. 705, 357–361. ( 10.1016/S0378-4347(97)00551-3) [DOI] [PubMed] [Google Scholar]
- 110.Tsuda T, Noda S, Kitagawa S, Morishita T. 2000. Proposal of sampling process for collecting human sweat and determination of caffeine concentration in it by using GCMS. Biomed. Chromatogr. 14, 505–510. ( 10.1002/1099-0801(200012)14:8%3C505::AID-BMC17%3E3.0.CO;2-7) [DOI] [PubMed] [Google Scholar]
- 111.Mena-Bravo A, Luque de Castro MD. 2014. Sweat: a sample with limited present applications and promising future in metabolomics. J. Pharm. Biomed. Anal. 90, 139–147. ( 10.1016/j.jpba.2013.10.048) [DOI] [PubMed] [Google Scholar]
- 112.Jadoon S, Karim S, Akram MR, Kalsoom Khan A, Zia MA, Siddiqi AR, Murtaza G. 2015. Recent developments in sweat analysis and its applications. Int. J. Anal. Chem. ( 10.1155/2015/164974) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113.Raiszadeh MM, et al. 2012. Proteomic analysis of eccrine sweat: implications for the discovery of schizophrenia biomarker proteins. J. Proteome Res. 11, 2127–2139. ( 10.1021/pr2007957) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114.Calderón-Santiago M, Priego-Capote F, Turck N, Robin X, Jurado-Gámez B, Sanchez JC, Luque de Castro MD. 2015. Human sweat metabolomics for lung cancer screening. Anal. Bioanal. Chem. 407, 5381–5392. ( 10.1007/s00216-015-8700-8) [DOI] [PubMed] [Google Scholar]
- 115.Bernier UR, Kline DL, Barnard D, Schreck C, Yost RA. 2000. Analysis of human skin emanations by gas identification of volatile compounds that are candidate attractants for the yellow fever mosquito (Aedes aegypti). Anal. Chem. 72, 747–756. ( 10.1021/ac990963k) [DOI] [PubMed] [Google Scholar]
- 116.Broza YY, Zuri L, Haick H. 2014. Combined volatolomics for monitoring of human body chemistry. Sci. Rep. 4, 1–6. ( 10.1038/srep04611) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117.Croxton RS, Baron MG, Butler D, Kent T, Sears VG. 2010. Variation in amino acid and lipid composition of latent fingerprints. Forensic Sci. Int. 199, 93–102. ( 10.1016/j.forsciint.2010.03.019) [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The section ‘Procedures and applications’ has been included in the electronic supplementary material.